SUMMARY. This paper reviews the current status of quality assurance in clinical biochemistry laboratories in Third World countries, particularly the developments in Singapore which in some respects are very similar to those of other developing countries. Some of the common problems are highlighted and recommendations for improvement proposed.
Although quality assurance programmes have been known to yield significant improvement in the performance of clinical biochemistry laboratories!' 2 and quality assurance has been a well-established practice and an accepted routine in many of the larger clinical bioclremistry laboratories in the developed countries, with few exceptions it has not been accorded the same degree of importance it deserves in the laboratories of the Third World. This has to do with the priorities and the organisation of health-care services in the Third World, ignorance, the general slowness with which any new developments and advancements are introduced into the existing practice in developing countries, and other difficulties. In many Third World countries, rapid population growth, malnutrition, and communicable diseases continue to be the major concern. Understandably, the resources for health-care have been channelled to the control, prevention and cure of such conditions, where clinical biochemistry has been given a less prominent role. The World Health Organisation (WHO), which has a significant influence over the developent of health-care services in the Third World, has for a long time concentrated on public health and diagnostic microbiology facilities. It was only in the early 1970s that the world body began to give greater attention to clinical biochemistry. A modest start in the promotion of quality assurance was made with the intro-'Part of this paper was presented at the Jubilee Meeting of the Association of Clinical Biochemists (West Midland Region) in Birmingham, England, in mid-July 1983, by Dr It-Koon Tan as an invited speaker. duction of an external quality assessment of glucose and urea estimations, with the view of improving and standardising two of the most frequently carried-out measurements in a routine biochemistry laboratory. Over the past decade, we have seen an increasing involvement of the WHO in quality assurance programmes for the Third World. For several years, a regular programme covering 15 common analytes in clinical biochemistry has been offered to a good number of countries. Several regional courses have also been conducted and special documents produced.i': 4, 5 Before WHO 'showed interest in the promotion of quality assurance programmes in laboratory work, some of the laboratories had introduced modest internal quality control programmes as a result of the initiative of their senior laboratory staff who were fortunate enough to have been exposed to the latest developments in laboratory practice. They had received practical attachments or training in some of the well-known centres in the developed countries where they could see the practice and application of quality assurance. They have established contacts with the laboratories in developed countries who were able to advise or assist them with the introduction of quality control measures in their own countries. An example of how overseas exposure and establishment of personal contacts had led to the early establishment of quality assurance programmes in some Third World countries is provided by our own experience in Singapore. From 1966, several clinical biochemists were sent to pursue professional qualifications overseas and to obtain practical experience and contacts necessary for the improvement and advancement of clinical biochemistry when they return to Singapore. The outcome of these educational and training programmes and opportunities to see the practice of clinical biochemistry in several different centres proved extremely fruitful.
In general, quality assurance in Third World countries is still in its infancy. Most of the programmes have been introduced only within the last few years, and are confined to the better staffed and better equipped laboratories in the larger cities. In many instances, these laboratories serve the premier national teaching hospitals. The programmes are also very limited in scope and frequency. Most ofthem are of the nature of external surveys, conducted only once or twice a year. They do not have sufficient impact on the improvement of the performance of the laboratories because of the lack of effective and comprehensive internal quality control programmes and the ability to trouble-shoot and correct any deficiencies and problems that have led to poor performances. However, a few laboratories have on their own initiative devised internal control programmes within their budget and subscribed to regular schemes offered by various commercial suppliers of quality control materials and programmes. To our knowledge, the Wellcome Clinical Chemistry Quality Control Programme which covers 28 analytes was the first to be introduced in the Southeast Asian region.
Quality assurance in some Third World countries
In the Asian-Pacific region, I have noted, through the presentations and contacts made during the first two regional congresses held in Singapore, that several countries have recently taken positive measures to implement quality assurance schemes as widely as possible. In Indonesia, the Ministry of Health is reported to have initiated a nation-wide programme by introducing legislation to make quality assurance compulsory in the field of laboratory care." This must be one of the very few countries, possibly the first in the Third World, to have taken legislative action. The whole of 1978 and the greater part of the following year were spent on a nation-wide but low-keyed campaign to 'precondition' the laboratories and laboratory user community. In various regions of the country, the Directorate of Laboratory Services organised meetings with laboratory directors and scientific staff, members of the College of Pathologists, relevant university staff and clinicians in public and private practice. Publicity on the need for and the purpose of quality assurance was made through the congresses and meetings of the relevant national medical associations and colleges as well as through television talks and the press. In order not to provoke any negative reaction and fear of reprimand among laboratory personnel, the term 'quality assurance' was chosen in preference to the term 'quality control'. In exhorting the laboratories to voluntarily participate in the national programme, the Directorate of Laboratory Services reiterated the following principles.
(1) Quality assurance is not identical with playing police. It does not look out for faults in order to take harsh measures but assesses a laboratory's performance in order to help improve performance with technical guidance.
(2) Quality assurance is for the benefit of both the laboratory and its user. With the enforcement of the programme, the laboratory user will be assured of more reliable test results, while the laboratory will benefit from technical guidance provided by the government. Laboratory participants are assured a high degree of confidentiality concerning their performance, so that the information would not be misused.
(3) The bulk of the cost of the programme will be borne by the government. Government laboratories will not need to pay for the programme, while private laboratories will need to pay only 20--30% of the operating cost.
(4) Government technical guidance teams will visit laboratories which show less satisfactory performance and provide the necessary assistance to correct deficiencies and improve their performance.
(5) For the initial 2-year period, quality assurance will be on a fully voluntary basis. However, after the grace period, participation in the programme will be a prerequisite for renewal of laboratory licenses. After a further 2-year period, a scoring system will be used as a prerequisite for the renewal of laboratory licences. The scoring system for evaluation of laboratory performance will be developed during the third 2-year period.
. As a result of the preconditioning, 67 laboratories (comprising 25 government and 42 private laboratories) participated in the first national survey involving the assessment of six analytes, in 1979. During the following year, 122 laboratories (comprising 42 government and 80 private laboratories) participated in a twice-yearly survey programme which covered seven analytes. By 1981, the number of participants increased to 172 (comprising 53 government and 119 private laboratories). From the surveys conducted in 1980 and 1981, a study of the technical errors and deficiencies was made and technical advice was given to the participants. As from 1982, a certificate of participation in the National Quality Assurance Programme was issued jointly by the Directorate of Laboratory Services and the Centre for National Quality Assurance Programme for the purpose of renewing laboratory licences.
A scoring system has recently been developed. The score 'point' for laboratory performance of a particular test is obtained by expressing the difference between the result obtained and the reference or designated value for the control specimen in terms of the standard deviation of the test method, squaring this number and subtracting it from 10. Thus, a result which is 1 SD away from the reference value will give a score point of 10 -(1)2.= 9, while a result which is 3 SD away from the reference value will give a score point of 10 -(3)2 = 1. The average value of the points for all test parameters will constitute the 'score' of the laboratory. With this method, good analytical performance is indicated by a high score. This scoring system was first implemented in a programme in 1982 which involved a record high number of 203 participating laboratories and nine test parameters. A list of the 50 highest and 50 lowest scoring laboratories was then obtained, which would be helpful in the selection of the future Indonesian national reference laboratories and the planning of a technical guidance programme. It is hoped that this national effort and determination to improve the quality of laboratory performance would stimulate greater awareness in the need for quality assurance and encourage the implementation of regular checks in daily analytical work in Indonesian laboratories.
While the initiative to conduct nation-wide surveys and assurance schemes came from the government in the case of Indonesia, elsewhere such undertakings are in the hands of either the WHO, the national associations or enthusiastic individual clinical biochemists who have had the right exposure and contacts.
Through the WHO and with the assistance of the Scottish Home and Health Department, a national monthly external quality assurance scheme (EQAS) was started in India in Septem- When an overall mean VIS of 150 or less is taken as indicative of satisfactory performance for these laboratories, less than half of the laboratories were found to satisfy this criteria, throughout the period." (UK and WHO EQAS use 100 or less as criteria for satisfactory performance.) Following the WHO sponsored programme, the Association of Clinical Biochemists of India introduced a regular 6-monthly interlaboratory survey for the assessment of the analytical performance of several common analytes. x The programme, conducted from the Department of Clinical Biochemistry in the Christian Medical College and Hospital in Vellore, initially attracted 59 laboratories. By April 1983, the number of participating laboratories has increased to 256. Although the concept of interlaboratory survey has recently become an accepted clinical biochemistry practice in India, results indicate that an adequate quality control programme has not been included as part of the routine work within the participating laboratories.
In Thailand, the laboratories are reasonably equipped and staffed. The first external quality assessment scheme was started in October 1980 under the sponsorship of the WHO and with the assistance of Professor T P Whitehead." The scheme involves the analysis of the 11 most common clinical biochemistry analytes at approximately 6-weekly intervals, and attracted 55 participating laboratories. By the end of 1982, about 100 laboratories, including private laboratories from all parts of Thailand were taking part in the scheme. This represents the vast majority of laboratories taking part in clinical biochemistry practice in Thailand. Performance is assessed by the use of the VIS. In January 1982, after more than a year's implementation of the programme, the overall mean running VIS (OMRVIS) for the 55 laboratories was 150 and 4 of these laboratories achieved a score of less than 100. Following visits from members of the International Federation of Clinical Chemistry (IFCC) Thailand Project Team to 16 laboratories which had participated in the first training course for Thailand, the OMRVIS of these selected laboratories decreased to close to 100 and the number of laboratories having a score of 100 or less increased from 4 to 8. The visit by experts to sort out problems and interpret the EQAS data was found to lead to a distinct improvement in analytical performance. Although the Iyophilised material for the scheme has been provided from the WHO Collaborating Centre for Research in Clinical Chemistry based at the Wolfson Research Laboratories in Birmingham, England, local distribution for the various laboratories is undertaken by staff of the Institute of Health Research in Chulalongkorn University, Bangkok. The Institute is also expected to take over the computer preparation of reports from the WHO Collaborating Centre sometime within 1983.
Despite the increasing reliance on clinical biochemistry laboratory service in the hospitals in Korea, especially after the introduction of a national medical insurance system in 1978,11 clinical biochemistry has not yet been established as a speciality in Korea. In general, the administration and supervision of the large hospital laboratories are in the hands of clinical pathologists even though their professional training may not have prepared them for clinical biochemistry work. In small and medium-sized hospitals, senior laboratory technologists are usually placed in charge of the clinical laboratories.
The first interlaboratory quality assessment in Korea was conducted in 1974 with 36 participating laboratories from major general hospitals. 12 Two years later, the Korean Society of Quality Control in Clinical Pathology was formed. In 1977, the Society initiated a periodic nation-wide programme using commercial Iyophilised assayed or unassayed sera. At the 4th International Symposium on Quality Con-trol held in Japan in 1981, representatives from the Society reported that in 1979, 46 laboratories participated in a seven-distribution programme which covered 20 analytes including five enzymes (note: apart from triglyceride, SGOT, SGPT, LDH, amylase, the other 15 analytes are identical with those covered by the WHO EQAS); and in 1980, 53 laboratories participated in a five-distribution programme covering the same analytes but excluding the enzymes. Most of the participating laboratories belonged to general hospitals with capacity of 100 beds or more. About half of these laboratories belonged to private hospitals while the remaining half served university and public hospitals. In 1979, results of individual laboratories were reported in terms of standard deviation (SD) and coefficient of variation (CV).
Apart from sodium, potassium, chloride, total protein and albumin, all other analytes gave CVs exceeding 10%. The largest CVs were obtained for the enzyme assays. They ranged between 20% and 42%. Excluding the enzyme assays, the overall mean CV for 15 analytes was 14·2%. From 1980, the VIS system was adopted as the basis of assessment and reporting of data was computerised. The computer-generated report included display of histogram and VIS for each individual analyte. An overall mean CV of 13·4% was obtained for 15 analytes while the overall mean VIS for 14 analytes (i.e. excluding triglyceride) for all participating laboratories was found to be 133.
In Malaysia, some of the laboratories serving the 13 largest hospitals (with 500 to 1000 beds) are known to practise some form of internal quality control and participate in the external assessment schemes conducted either by the WHO or a commercial firm or both. In a recent review on the status of health laboratory services in Malaysia, a leading chemical pathologist of the country commented that the analytical performance of some laboratories has not matched those of the few premier laboratories partly because of the absence of any quality assurance programmes. 12 He expressed the desire for a national quality assurance programme for all laboratories. It was suggested that there should be full-time, on-site involvement of qualified professionals so that laboratory analytical performance might be effectively monitored and improved.
The establishment of a regular regional congress and a newsletter for the African and Mediterranean region has provided many Third World countries in the region with better means of communication and opportunities to share experience, problems and expertise. The status of laboratory practice, education and training, and problems of quality control were among the most important topics highlighted in the first regional congress. In a report, a leading clinical pathologist from the region lamented that in developing countries in Africa, training programmes in quality assurance are painfully inadequate.P Apart from some efforts by the WHO, there has been no real input to establish educational programmes at any level on a continuing basis. Even the WHO-sponsored programmes have been limited to only a small proportion of the larger laboratories and involved very few high level laboratory personnel. There is no provision in the curricula of medical schools for the teaching of quality assurance. In the teaching of medical laboratory technologists, the subject of quality control merely received a passing reference and has been confined to definitions on accuracy, precision, mean value, standard deviation and coefficient of variation. In some cases, laboratory personnel are made more confused and apprehensive by various types of terminologies which describe identical statistical indices.
With the exception of few premier laboratories serving teaching hospitals and research centres funded by international organisations, the state of the art of internal quality control in most laboratories in developing countries in Africa is reportedly poor. Some laboratories do not have any visible system for monitoring performance. The attitudes of staff, inadequacy of training, high cost of control and standard reference materials are some of the reasons which account for the present status. A small number of external quality assessment prorammes are conducted in African countries. Unfortunately, these have been erroneously regarded as substitutes for internal quality control. Several countries including Nigeria, Sudan, Zambia, Gambia, Ghana, Ethiopia, Kenya, Liberia and Uganda participate in the EQAS sponsored by WHO and organised from the UK. As this scheme has been extended only to the peer laboratories in the various participating countries and since the samples are said to be handled with considerable reverence, sometimes by the laboratory directors themselves, the results are not representative of the actual overall performance status of laboratories in the respective countries. Some laboratories subscribe to an external quality assessment programme offered by a commercial organisation.
More recently, a third external quality assessment programme was organised and introduced by Akinyanju and Louderback for laboratories in Nigeria.P The scheme is completely confidential and began with the assessment of the following 12 analytes: sodium, potassium, chloride, bicarbonate, glucose, urea, creatinine, total protein, albumin, uric acid, cholesterol and phosphate. The liquid control material, provided in a 5 ml glass ampoule, has been shown to be stable at room temperature. Besides the advantage of its relative stability and easy storage condition, the liquid control also eliminates the need for reconstitution required for Iyophilised materials, which is known to give rise to errors in the process of reconstitution and as a result of inaccurate pipetting. Participation in this scheme is entirely voluntary and free of charge. Participants receive a detailed protocol explaining the reasons for the scheme and the way the data will be analysed and presented. The scheme is intended to serve all types of laboratories including those in small clinics and in the private sector. For the first assessment which spread over a period of several months, three controls at different concentrations of analytes were used. The results of the individual participating laboratory were compared with the mean, SD and CV of all participants in Nigeria as well as the mean and performance range of ± -2 SD obtained for the same controls by 185 laboratories in the USA. In subsequent assessments, standards will be provided along with the unknown control samples for each participant. This will enable the scheme to evaluate the extent to which poor standard preparations contribute to poor analytical performance. Eventually, the Nigerian Association of Clinical Chemists is expected to take over the administration of the entire scheme.
The Singapore Experience
In the 1950s and early 1960s the only form of quality control that existed in the central reference laboratory in Singapore was the close supervision of laboratory work by the biochemist in charge. He emphasised the importance of cleanliness, careful weighing and pipetting and meticulous attention to details. He personally scrutinised all calculations and vetted all reports. Some analyses were made in duplicate and an occasional repeat analysis was carried out to check the reproducibility of results. From 1955, hospital clinical laboratories were asked to send specimens to the central reference laboratory for repeat analysis to assess whether these laboratories give results that are close to those obtained by the reference laboratory. This practice continued for several years until the beginning of 1969 when the first biochemist who had been sent to the UK for training returned from his study. Having been exposed to the practice of quality assurance in routine analytical work in UK, particularly in the Clinical Chemistry Department of the Queen Elizabeth Medical Centre in Birmingham, he began to introduce a systematic programme for quality assurance for clinical biochemistry laboratories in Singapore.
As our laboratories employed only manual methods for all analyses in early 1969 and as the rapid increase in workload was becoming an important cause for variable analytical performance, the first step towards the improvement of quality of analysis was the simplification of work. Automatic dilutors, dispensers and pipettes were therefore introduced. Methods requiring protein precipitation with centrifugation and transfer of supernatant, were replaced with techniques which do not require protein precipitation. Flow-through cells were introduced and this eliminated the tedium of repeated transfer of solutions from test tubes to cuvettes. In addition to these measures, the concept of assaying 'quality control' specimens along with patients' test specimens was introduced. Thus, a programme of quality control involving the use of laboratory prepared pooled serum was introduced in the same year. The budget for the year did not provide for the purchase of commercially available lyophilised serum. However, as left-over patients' serum was readily available and cost nothing, this material was pooled and introduced for the quality control of most of the routine tests. A desk-top calculator was used for daily calculations of means and SDs.
An external quality assessment scheme was also introduced to our laboratories in 1969. This was the International Laboratory Proficiency Survey conducted by the College of American Pathologists. Four lots of freeze-dried sera and urine samples were received from the College at various times of the year. The analyses made on the sera were: glucose, urea, calcium, total bilirubin, cholesterol, potassium, sodium, uric acid; and those on the urine samples were: specific gravity, protein, reducing substances, bilirubin and haemoglobin. When our results were compared with those obtained from other participants, the general performance of our laboratory was reported to be within the limits of acceptable and good performance. This programme was continued for several years.
The initial introduction of quality control was not without resistance from some members of the staff. They questioned the need for spending so much extra time and effort on such measures. However, when a number of systematic errors were identified by the programmes, and when the benefits of quality control became apparent with time, their resistance gave way to an increasing conviction of the usefulness and importance of routine and regular quality assurance programmes. With a change in attitude, implementation of further measures of quality assurance was not a difficult task. Thus, when funds became available in 1970, commercially prepared freeze-dried sera with known concentrations of analytes were purchased to complement the use of pooled sera for daily monitoring of a wide range of laboratory analyses.
The acquisition of a mini-computer in early 1974 greatly facilitated the storage of analytical data, and calculation and charting of quality control statistics. It has since been the daily routine practice of our laboratory to compare the results obtained on five control sera with different concentration levels for each analyte, with the running mean and SD obtained for the same sera over the last 30 days. The average CVs for 14 analytes, calculated from results obtained over a period of time, is given in Table 1 .
In addition to the use of analytical data on frozen pooled serum and commerciallyophilised serum for the purpose of internal quality control, results on patients' test specimens were also employed. After suitable truncation of values higher or lower than a predetermined limit, the mean and SDs calculated from patients' test results have been carried out for 15 of the most common tests. Cusum plots of the daily mean values for the 15 tests, according to the method of Whitehead and Morris.!" is provided by the computer at the end of the day.
In order to compare our performance with a sufficiently large number of laboratories using similar methods and instruments, our central reference laboratory began to participate in the Wellcome International Group Quality Control Programme conducted by Wellcome Reagents Ltd, in 1972. The programme comprises two TABLE 1. Average coefficient of variation obtained using different pooled sera as quality control specimens (1978--1982) 6-monthly cycles and covers 21 analyses. Lyophilised sera are assayed at fortnightly intervals. Reports showing computer print-out distributions of test results from more than a thousand participating laboratories from all over the world are received within 10 days of submission of results. A summary report giving the performance and ranking position for individual test methods as well as the overall performance and ranking for all tests carried out by the individual laboratory, in comparison with others, is presented with appropriate comments at the end of every 6 months. To date, the performance of our laboratory in this programme has been given a fair rating. Quality assurance in the Third World 199
In the same year, our laboratory was invited to participate in the International Glucose-Urea Standardisation Programme conducted jointly by WHO and the Centre for Disease Control (CDC) of the United States Department of Health, Education and Welfare in Atlanta, Georgia. The first part of the WHO-CDC programme consisted of analysis of glucose and urea in 10 pairs of lyophilised sera over a lO-week period at weekly intervals. In the second part of the programme, aqueous control solutions were supplied for 26 runs of lyophilised sera. According to a report by CDC, our laboratory performed well during the entire period of assessment. The programme which was aimed at assessing the performance of glucose and urea methods in current use with the view of standardisation was repeated once and subsequently discontinued.
Following the programme for glucose and urea, WHO-CDC conducted a two-part programme for the assessment of performance in cholesterol and triglyceride analyses. We were one of the 20 laboratories which showed satisfactory performance in Part I of the programme and were allowed to proceed with Part II of the programme. Our performance in the second part of the programme credited us with being considered a standardised lipid reference laboratory for the region.
Nothing more was heard from either the WHO or the CDC, until September 1977 when we were invited to participate in the WHOsponsored international external quality assessment scheme (EQAS). The improvement in our laboratory performance as shown by this scheme over the years, is given in Fig. 1 . A national interlaboratory quality assurance scheme for government hospital laboratories was launched in October 1972. Aliquots of frozen pooled serum or reconstituted lyophilised serum were distributed by the central reference laboratory to the hospital laboratories for daily analysis of urea, glucose, potassium, sodium, and chloride, which are the most commonly performed biochemical tests in these laboratories. Results obtained by each laboratory are reported to the central reference laboratory by telephone. Reports giving the VIS score for individual as well as all participating laboratories are now being provided for the laboratories at the end of each day. At the end of each 6G-day cycle, a meeting is held to discuss results with the supervisors of all the laboratories. In the meantime, should any conspicuous outlier results be noted, the laboratory reporting such results would be alerted by telephone immediately and possible causes for the anomalous results explored, so that early remedial action can be taken. The current practice of quality assurance and the recent results of performance by various government hospital laboratories in the national interlaboratory programme are shown in Fig. 2 and Table 2 . The national programme has been responsible for improving the quality of analytical performance of all the participating laboratories as well as the standardisation of methods and instruments used by the laboratories. 
Some common problems in Third World countries
The problems encountered by laboratories in Third World countries vary enormously from country to country and from laboratory to laboratory within the same country. Only the more common ones will be highlighted in this paper. sis of that specimen, and the correct transcription of patient information and test results on a laboratory report. Unfortunately, it is not uncommon to find that ward staff responsible for specimen collection do not know the precautions and the importance of positive identification. Some may not be aware of the effects of long standing and storage at the wrong temperature on various analytes in the specimen while others are ignorant about the effects of inappropriate anticoagulants and preservatives, drug therapy and other investigation procedures that can affect analysis either through chemical or physiological interference.
No amount of care taken by the laboratory staff at the time of analysis will ensure that a correct result is returned to the clinical staff when gross errors or changes have already occurred during the collection, storage or transportation of the specimens. Laboratory quality control is a futile exercise if the necessary precautions are not consistently observed by those responsible for the specimens up to the time of actual analysis. Rather sadly, there is a general lack of awareness in the need for quality control before the specimens are put through analysis and little has been done in many Third World countries to educate both laboratory staff and users of laboratory service.
At the laboratory end, there has been a tendency for laboratory personnel in many developing countries to embark on quality assurance programmes without fully understanding their implications. Quality control often means the mere inclusion of one or more standards and a control specimen in every batch of analysis, the computation of results based on the value of the standard and the comparison of the result obtained on the control specimen with the assigned value for the specimen. Although some have gone a step further to plot the" results from control sera daily using Levy Jenning's method, little may be done when analytical values exceed the acceptable limits because of the inability to interpret quality control data and ignorance as to the likely causes of errors and ways of correcting and avoiding them. Failure in understanding statistical presentations of results provided by various external assessment programmes has led to misinterpretation of quality control data. Some laboratories assumed that if a result lies within the ± 2 SD of a histogram, it must be 'satisfactory'. They do not realise that if the histogram print-out consists of mainly unsatis-Quality assurance in the Third World 201 factory results, the magnitude of the SD can be significantly affected by such results and their assumption is not valid. Those responsible for introducing quality control measures to the laboratory have either (1) not taken the trouble to educate laboratory staff for the tasks of interpreting data, trouble-shooting, correcting errant techniques and instrumental malfunction, or (2) not been adequately trained themselves.
In some laboratories, quality control specimens for an EQAS are given special treatment. Extra care is taken in handling these specimens and duplicate or triplicate analysis may be carried out to ensure that 'good results' are obtained. Sometimes, a very senior staff member or the laboratory director may carry out the analysis for these 'revered' specimens separately from patients' test specimens. Therefore, a laboratory can have a satisfactory or good report for an external programme which unfortunately does not necessarily reflect the actual state of its general performance. Unless serious misconceptions regarding the purpose and use of quality assurance programmes are corrected, time, effort and money spent on these programmes will be wasted. What could be worse is the false impression that the laboratories are performing well when they are not.
(B) DEFICIENCY IN THE EDUCATION PROGRAMME FOR LABORATORY PERSONNEL
Although in an attempt to keep up with modern laboratory practice, many laboratories have introduced internal quality control and are participating in some form of external assessment scheme, these measures have not achieved the intended objective of improving laboratory performance in every laboratory. The failure may be largely attributed to deficiencies in the basic education and training programmes for laboratory personnel and lack of opportunities for laboratory workers to participate in scientific meetings and learn from others. Consequently, laboratory staff have not learned the basic principles of good laboratory practice and housekeeping which include precautions essential for each analytical method, care required for the operation and maintenanceofvarious apparatus and intruments, and need to ensure the quality of chemical reagents and their storage under suitable conditions. They are not aware of the following situations which can lead to erroneous results: use of unclean glassware, use of inaccurately calibrated pipettes, use of a faulty balance, error in calculating the weight of a substance to be used as standard because of lack of awareness in the difference in the molecular weight caused by a change in the type and number of metallic ions or water molecules in a new batch of purchased chemicals, use of a spectrophotometer with altered wavelength calibration, use of unmatched cuvettes for measurement of absorbance, making calculations based on molecular absorbance when the spectrophotometer does not give accurate absorbance readings, and use of water and chemicals which are insufficiently pure for analytical purposes.
It is not often appreciated that the quality of water and chemical reagents can have a significant effect on analytical performance. Consequently, insufficient emphasis has been placed on the routine monitoring of the suitability of water and chemicals. The use of poor quality water and reagents could be an important contributory factor to unsatisfactory and variable performance in some laboratories. In our experience, different batches of sulphuric acid and magnesium carbonate may not be of the same quality and can cause considerable problems with analysis for cortisol and total ironbinding capacity respectively. The variation in quality of reagent is noted even for the same reputable manufacturer.
Manual methods are still employed by many clinical laboratories in the Third World. Although minor variations in the calibration of pipette volume may be tolerable in methods in which test specimens and standards are put through exactly the same procedure, even slight inaccuracy in volume calibration can cause considerable bias in the results if different pipettes are required for standard solutions and test specimens. This has been the experience of some laboratories which have to use inferior pipettes produced by local manufacturers who obviously have not subjected their products through a rigorous quality control programme.P If laboratory staff are aware of this, they would have made a systematic evaluation of the pipettes before accepting them for routine use.
There has been an increase in the use of work-simplification devices, such as autodilutors and dispensers in laboratories. The accuracy and reproducibility of these apparatus have been too readily accepted by their users. In the event of questionable analytical performance, they are often least suspected as being the possible cause of the problem. Lack of knowledge for assessing the performance characteris-tics of these devices has prevented laboratory personnel from identifying their imperfections.
Many laboratory staff assume that a spectrophotometer supplied to them always reads correctly, provided that there is no noticeable drift in the readings which indicates obvious problem. They do not realise that depending on the use and treatment the instrument has been subjected to, there could be shifts in wavelengths and deterioration of the optical and light-detecting components which render the absorbance readings incorrect. Our experience tells us that even with identical models supplied by the same manufacturer, absorbance readings between the instruments may not agree due either to imperfection of the instrument or changes in calibration or alignment during packaging and transportation. It is quite common for a laboratory with a high workload for enzyme assays to use two or more spectrophotometers. This assumes that the two instruments give identical readings. However, the true situation may be otherwise and variable results will be obtained. It is a even more common situation to find laboratories performing enzyme assays at 340 nm without first checking if the spectrophotometer gives correct readings. As calculations of enzyme activities for such assays are often based on the molecular absorbance of NADH or NADPH, with the assumption that the spectrophotometer used is capable of giving accurate readings, one can imagine the effect an inaccurately calibrated instrument has on the results.
Unfortunately, manufacturers of some test reagent kits have also made the same assumption which may only be applicable in the more advanced laboratories. This has added to the false sense of trustworthiness of spectrophotometric performance. Some time ago, a reagent manufacturer offered a simple amylase assay kit for use in our laboratories. Included in the kit was a 'calibration curve'. However, no standard or calibration solution was provided for the checking of the applicability of the standard curve or for making any corrections. When the same enzyme reaction mixture was read in the spectrophotometers belonging to several hospital laboratories, we noticed quite a considerable difference in results. As no allowance has been given by the supplier for the correction of the variability in spectrophotometric readings, we found it difficult to accept the reagents for routine use by our laboratories.
With instruments which provide direct readout of results in concentration units without the need for a standard which has been subjected to the same treatment as the test specimens, there is a tendency for laboratory staff to accept the readings too readily. When no periodic checks on the accuracy of the instrument are undertaken, the results can be grossly incorrect without anyone noticing them. An example of such an instrument is the Bilirubinometer marketed by American Optical which is widely used by many hospital laboratories for the measurement of serum total bilirubin in paediatric patients. We found that with age and constant use, the 'reference standard' filter for calibration can deteriorate and cause erroneous readings. We had to introduce periodic checks using either a dichromate solution with designated value or a commercial control to monitor the quality of the reference standard filter.
One particularly acute and difficult problem faced by some countries is the lack of suitable comprehensive instruction materials on quality assurance in the native language and at a level which could be understood by all grades of technical staff. The multiplicity of languages and dialects, even within the same country, has hindered effective communication and hence the spread of education. Consequently, laboratory staff are ill-equipped for the practice of proper quality assurance in their routine work.
(c) SHORTAGE OF TRAINED PERSONNEL
Because of the relatively low priority given to the development of facilities for centralised clinical biochemistry laboratory service, many countries have not made adequate provision for the training and employment of professional and technical personnel. Fragmentation of services because of the demand of various clinical departments for their own departmentallaboratories leads to a competition for the limited number of skilled technicians and adds to the problem.
Many laboratories are administered only by middle grade laboratory technicians. Even in the more fortunate laboratories, there may only be a senior laboratory technician in control. Although some larger regional laboratories and university hospital laboratories employ senior medical officers or qualified pathologists as supervisors, these staff may not have interest and commitment in clinical biochemistry nor the necessary training to do a good job. Compared with the other categories of staff, the clinical biochemist belongs to a relatively rare species in the Third World. Under the prevailing circumstances, it would be hard to expect Quality assurance in the Third World 203 many Third World laboratories to reach a standard of laboratory performance comparable to that achieved by the advanced laboratories, in the near future. Due to a variety of reasons which include a small workload and constraints of funds, many laboratories have to rely on non-automated instruments and therefore manual methods. To the staff who have to carry out the analysis, the inclusion of every additional specimen for analysis is an added burden. Therefore, the daily use of quality control specimens to monitor analytical performance is not received with enthusiasm, especially when laboratory staff have the misconception that this routine is aimed at seeking out their weakness and faults. On the other hand, when some laboratories have the opportunity of acquiring automated equipment, the ease of handling additional specimens and the over-confidence in the capabilities of automated instruments tend to encourage a lax attitude and a decline in the care and precaution which staff would normally have taken when using a manual method. It is not obvious to them that automated instruments too have their limitations and good performance can only be obtained by ceaseless efforts in observing all the necessary precautions for operation, proper maintenance of instruments, accurate preparation of standards, and regular checking of reagents.
The inaccessibility or lack of competent and efficient local services for the maintenance of instruments is a common and serious problem. This makes it difficult if not impossible to identify defective components and malfunctions which give rise to poor analytical performance. Several years ago, when our quality assurance programmes indicated that all the enzyme measurements performed on one of our kinetic rate analysers were running high, we checked all possible sources of error that might arise from the reagents and instruments. Eventually, we suspected that the temperature might have risen because of a faulty thermostatic device in the analyser. The only way to confirm our suspicion was to measure the actual temperature of the contents of the cuvette during incubation. However, the design of the instrument did not permit easy access to the cuvette when it was moved into the heated compartment. The local agent was unable to help. After much correspondence and waiting, an engineer from the manufacturing firm came and confirmed that there had been a shift in the temperature control leading to an overheated compartment. The fault was quickly rectified and the local agent was then asked to keep a special set of tools to check on the temperature setting of the instrument should a similar situation recur. I must confess that in general, we have not encountered too many problems with equipment maintenance in Singapore. Many other countries are not as fortunate.
(E) AVAILABILITY OF CONTROL MATERIALS
In general, commercial Iyophilised control materials are not readily available in the Third World countries. Among the reasons for this limited availability is the low purchasing power and hence inadequate demand and small consumer market, various import restrictions, complexities and delays in customs clearance, and storage problems. The single major reason is the prohibitive cost of the materials which has prevented their widespread use in routine internal quality control programmes. Comprehensive technical information and educational programmes in the form of newsletters, seminars, workshops and training courses on the nature, limitation, and use of control materials which are available in most advanced countries are also scarcely available in the developing countries.
An outstanding problem encountered in the use of the commercial control materials is the difficulty of comparing results obtained by the laboratories using manual methods with the values assigned for the control sera which have been based on a whole host of methods and sophisticated semi-automated and automated instruments widely used in the advanced laboratories. The dilemma faced by laboratory staff is the selection of the correct designated values for comparison, since information relevant to the methods used in their laboratories are not given.
Some laboratories have resorted to the use of pooled sera. However, the majority are unable to do so because of one or a combination of the following reasons: limited availability of suitable sera left over from analysis, instability of sera, lack of suitable cold storage facilities, lack of knowledge for the preparation of pooled sera with designated concentration levels, and difficulty of assigning values for the sera.
(F) LIMITATION AND RELIABILITY OF

REFERENCE AND CONTROL MATERIALS
The need for the inclusion of non-human material in the preparation of commercial control sera with different concentration levels has created special problems, especially for assessing the performance of enzyme measurements. Enzymes obtained from microorganisms, plants and other animals do not always react in the same way as those present in the human sera. The wide variety of experimental conditions and instruments being used by the different laboratories for enzyme assays add to the problem. One can therefore expect a large variation in results on the same control sera, which makes comparison with the assigned values extremely difficult. This difficulty seriously limits the usefulness of commercial control materials for monitoring enzyme analyses.
In some Third World countries, the reliability of reference and control materials depends very much on the conditions of storage by the local suppliers and the users, as well as on the care taken in the reconstitution and subsequent handling of the materials On one occasion when great difference in~Ikaline phosphatasr esults was observed on the same batch of control sera, we discovered that our local supplier had stored some of the sera at room temperature!" (Fig. 3) . However, despite the observation of all necessary precautions, we have found occasional inconsistencies in the concentrations of various analytes even within the same batch of materials, supplied at the same time and stored under identical conditions. This appears to indicate that there could be occasional fluctuations in the quality of commercial products.
A year ago, when the manual two-point method for our creatine kinase determination was replaced by a kinetic procedure which uses N-acetyl cysteine for activation, results in a commercial interlaboratory quality assessment scheme showed random fluctuations often beyond acceptable limits. However, when we examined results obtained on control sera supplied by another manufacturer which had been included within the same batch of analysis, we were surprised to note that the results for these sera did not follow the same pattern. Instead, they indicated satisfactory performance. This led us to a study on the behaviour of creatine kinase in several commercial products for quality control. We found that unlike human sera, many of the Iyophilised materials contained an enzyme which gives variable activity depending on the length of time of preincubation with the activator. It was con- eluded that several control materials studied were unsuitable for use with our current method for creatine kinase.'? This experience shows that results based on commercial Iyophilised materials do not always give a reliable indication of the performance of every test method. Introduction of automated analytical systems such as the continuous-flow analysers has necessitated the use of commercial reference materials for instrument calibration, particularly for protein and enzyme determinations. The accuracy and reproducibility of results are therefore highly dependent on the quality and reliability of the reference materials. In our experience, we found that when reference materials produced by one manufacturer were run against those produced by another, the results obtained were often quite different from the values designated. Thus, significant variation in results were obtained for the same test specimens when different reference materials were used for calibration. Similar observations have been made by others. IK, 19, 2U It was noted that different commercial reference sera differed significantly from each other with regard to different constituents. Furthermore, different lots produced by the same manufacturer also differed from one another. This raises doubts as to the reliability of using the designated values of reference materials for instrument calibration and the question of what the true or absolute values of the materials are.
The difference between stated values and measured values of the reference materials are sufficiently marked to prevent a laboratory from receiving a good performance or even an acceptable performance rating in an interlaboratory quality assessment programme. Because of cost consideration and supply prob-lems, many laboratories cannot avoid the purchase of reference materials from different manufacturers. With every change of supplier, there is a need to determine the 'adjustments' required for the assigned values. In our laboratory, the adjustment is determined by comparison with a small lot of reference sera specifically purchased from the same manufacturer who supplied us the analyser and the reference sera which had been used for establishing local reference values and for routine analytical work, for a period of at least 2 years. Further adjustment may be required when results show significant deviation from the mean values reported in interlaboratory assessment programmes. This is not the most satisfactory solution, since we assume (1) uniform quality and reliability of different lots of reference materials from the same manufacturer, and (2) the correctness of the mean values obtained in the interlaboratory surveys, which could be biased.
It would appear that a great deal of work is still required for the improvement of the reliability of reference and control materials, which are themselves creating problems.
Some suggestions and recommendations
In order to promote and advance the practice of quality assurance in the Third World laboratories effectively, it is necessary to improve the education and training programmes for laboratory personnel and correct any deficiencies in the existing programmes. For some, there is an urgent need for the supply of comprehensive educational material in a language and at a level that can be understood by all levels of laboratory staff. This is an area where the International Federation of Clinical Chemistry (IFCC) , the WHO and regional or national professional associations can play an important role. Many training courses on quality assurance have been developed from experience gained in advanced countries. These have assumed that laboratory staff have already attained an expected level of competence and knowledge, and are appreciative to various analytical problems, so that they are well equipped to identify sources of errors and take necessary corrective actions independently. They have not taken into consideration the extremely varied and usually lower level of training received by laboratory personnel in Third World laboratories and the various constraints and limitations within which they have to work. Therefore, courses which merely emphasise the methods of carrying out quality control are inadequate and incomplete. They should include basic concepts and principles of total quality assurance, knowledge of good laboratory housekeeping, likely sources of errors arising from analytical methods and instruments, basic care of instruments, interpretation of quality control data, and actions required to correct poor performance. At present, the WHO is conducting an EQAS for a number of countries. It would be useful if this could be extended to cover more laboratories. It would also be helpful if the organisation can help to identify the specific problems of those laboratories which consistently give poor performance, over a long period of time.
Commercial firms can assist by providing comprehensive information on their products. Translation into the local language would be necessary if the commercial control materials are to be used meaningfully and according to the instructions and specifications of the manufacturers. Those providing an external quality assessment scheme have the responsibility of educating the participants in the interpretation of the various reports. Whenever necessary, the usual presentation of reports may need to be modified for the benefit of an individual participant.
WHO could be more active in helping laboratories to establish their own internal quality control programmes. Laboratory staff could be taught to prepare and use pooled sera with different concentration levels. For practical and economic reasons, they should also be taught to prepare stabilised aqueous control materials for non-enzyme assays.
The organisation of regular regional congresses such as those for the Asian-Pacific, African-Mediterranean, and Latin-American regions, will provide the much-needed opportunities for Third World countries to communicate and share experiences with one another, and to learn from those working in the more advanced laboratories. It would be good if WHO and IFCC could provide funds to encourage attendance at the regional meetings. They could organise specific courses on quality assurance and other aspects of clinical biochemistry to coincide with the meetings in order to maximise attendance and minimise cost.
It has been reported that surveys on spectrophotometers have shown particularly poor performance in terms of optical absorbance and wavelength selection.r': 22 Much more needs to be done to monitor the performance of a wide range of instruments. The reliability of reference and control materials also remains a matter of great concern for many laboratories. It is hoped that a concerted collaborative effort will be made by the WHO, IFCC, various regulating bodies, committees on standards, and commercial firms towards the achievement of a satisfactory solution to this very acute and disturbing problem.
